China tightens oversight of contract manufacturers and traders
This article was originally published in SRA
Executive Summary
To curb the exportation from China of fake and low-quality drugs, the State Food and Drug Administration has issued a new regulation that targets domestic contract drug manufacturers receiving orders from foreign buyers1,2.